The leading software solution for DIA proteomics is compatible with MS instruments from all major vendors, including Bruker Daltonics, and Thermo Fisher Scientific SCHLIEREN, Switzerland — Biognosys, ...

Spectronaut® 19 offers significant improvements in identifications, candidate discovery, scalability for large-scale analysis, and support for novel workflows Novel TrueDiscovery® P2 Plasma Enrichment ...

The Biognosys Group, a leader in mass spectrometry-based multiomics, announces advancements across its integrated multiomics ...

ZURICH, Switzerland and CANCUN, Mexico, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Biognosys, a leader in next-generation proteomics solutions for life science research and drug development, will launch ...

(MENAFN- GlobeNewsWire - Nasdaq) ZURICH and BOSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Biognosys, a global leader in mass spectrometry-based proteomics solutions, announces the launch of Spectronaut ® ...

Novel research with TrueDiscovery™ and TrueTarget™ demonstrates the unique capabilities and utility of mass spectrometry proteomics for biomarker and drug discovery Biognosys’ iRT Kit is recommended ...

Biognosys AG has announced the second release of its Spectronaut™ software for analysis of Hyper Reaction Monitoring (HRM) data. HRM is a targeted proteomics technology that enables reproducible and ...

Data-independent acquisition (DIA) has become the method of choice for large-scale discovery proteomics. Its application for single-cell analysis promises to be more sensitive, robust, and ...

SCHLIEREN, Switzerland--(BUSINESS WIRE)--Biognosys, a leader in next-generation proteomics solutions for life sciences research and development, announced today the launch of Spectronaut 15. The ...

Spectronaut® 18 makes DIA proteomics projects more efficient and scalable than ever for all mass spectrometry instrument types Novel research with TrueDiscovery™ and TrueTarget™ demonstrates the ...